ロード中...
MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart
Cardiovascular disease is the number one cause of morbidity and mortality in the United States. The most common manifestation of cardiovascular disease is myocardial infarction (MI), which can ultimately lead to congestive heart failure (CHF). Cell therap (cardiomyoplasty) is a new potential therape...
保存先:
| 出版年: | J Cardiovasc Pharmacol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4452997/ https://ncbi.nlm.nih.gov/pubmed/25658461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0000000000000183 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|